• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Ampio Pharmaceuticals Inc

+ Add to Watchlist

APH:GR

3.234 EUR 0.322 9.06%

As of 02:17:49 ET on 10/20/2014.

Snapshot for Ampio Pharmaceuticals Inc (APH)

Open: 3.232 Day's Range: 3.232 - 3.294 Volume: 0
Previous Close: 3.556 52wk Range: 2.561 - 7.606 1-Yr Rtn: -46.55%

Stock Chart for APH

No chart data available.
  • APH:GR 3.294
  • 1D
  • 1M
  • 1Y
3.556
Interactive APH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for APH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.8100
Est. PEG Ratio -
Market Cap (M EUR) 168.08
Shares Outstanding (M) 51.97
30 Day Average Volume 95
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for APH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for APH

Ampio Pharmaceuticals, Inc. researches and develops drugs. The Company researches treatments for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The Company's product pipeline includes some new uses for previously approved drugs.

Michael Macaluso JrChairman/CEOGregory A GouldCFO/Treasurer/Secretary
Joshua R Disbrow "Josh"Chief Operating OfficerDavid Bar-OrChief Scientific Officer
More Company Profile & Key Executives for APH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil